ARCHIVES

Faulding, NaPro In Agreement For Marketing Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility

February 1, 1980

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

November 19, 2004

Abstracts Of Papers Presented By Breast Cancer Task Force

September 17, 1976

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003